TANG CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001232621

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth Tilt how tags are computed

Q3 2026 · 45 positions · Total reported value $2.17B · Top-10 concentration 64.3% · Updated 2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

Turnover: 15.2% · 5 new · 1 cut · 1 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -8.5% · vs SPY -10.6% · Prev Value $2.20B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.0% · vs SPY -5.2% · Latest Value $2.17B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, TANG CAPITAL MANAGEMENT LLC disclosed 45 equity positions with a combined reported value of $2.17B. The filing implies a focused portfolio: its ten largest positions account for 64.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt.

The largest disclosed positions as of Q3 2026 were AUPH ($211.25M), CORT ($172.84M), KNSA ($168.61M). By sector, the heaviest allocations are Health Care 89.7%, Information Technology 1.5%. Versus the prior quarter, allocation shifted toward Information Technology (+0.6pp) and away from Other (-0.6pp).

Versus the prior quarter, TANG CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 1 and fully exited 1, a turnover rate of 15.2% of positions. The portfolio's overlap with the prior quarter was 87% of names.

The largest new positions opened in Q3 2026 were ARDX ($30.94M), VERA ($16.14M), LEGN ($13.92M).

Of the 1 positions fully exited versus the prior quarter, the largest were CAPR ($98.73M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • ARDX ARDELYX INC · $30.94M
  • VERA VERA THERAPEUTICS INC · $16.14M
  • LEGN LEGEND BIOTECH CORP · $13.92M
  • SION SIONNA THERAPEUTICS INC · $657.50K
  • SKYE SKYE BIOSCIENCE INC · $322.00K

Fully Exited (vs previous quarter)

  • CAPR CAPRICOR THERAPEUTICS INC · prev qtr: $98.73M

Insider Transactions (Form 4)

Latest TANG CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-10 Buy Boundless Bio, Inc. 249 $2.40 SEC filing
2026-11-06 Buy Boundless Bio, Inc. 1,700 $2.40 SEC filing
2026-11-05 Buy Boundless Bio, Inc. 8,390 $2.40 SEC filing
2026-11-04 Buy Boundless Bio, Inc. 517 $2.40 SEC filing
2026-11-03 Buy Boundless Bio, Inc. 2,255 $2.40 SEC filing
2026-10-27 Buy Boundless Bio, Inc. 10,707 $2.40 SEC filing
2026-10-26 Buy Boundless Bio, Inc. 9,606 $2.38 SEC filing
2026-10-23 Buy Boundless Bio, Inc. 6,234 $2.38 SEC filing

All insider transactions →

Fund Profile

Tang Capital Management is an SEC-registered 13F filer. As of Q3 2026 it reported 45 US equity positions with a combined value of $2.17B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Portfolio Structure

  • 45 positions · $2.17B reported value (Q3 2026)
  • Top 10 holdings = 64.3% of reported value
  • Largest position: AUPH (AURINIA PHARMACEUTICALS INC) at 9.7%
  • Average position size: $48.31M

Sector Tilt

  • Health Care 89.7%
  • Information Technology 1.5%
  • (classified holdings cover 91% of value)

Quarterly Activity

  • Q3 2026: 5 new, 12 added, 1 reduced, 1 exited
  • 27 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund increased exposure to select biotech/healthcare names (TARS, LKFT, CELC, IMCR) while trimming others (MIRM, PTCT), suggesting a tactical tilt toward undervalued or high-potential therapeutics amid sector volatility. 2. Key moves: - Added: TARS (+22.3% shares, wt↑1.45ppt), LKFT (+5.3% shares, wt↑0.28ppt), CELC (+11.4% shares, wt↓0.89ppt but action=Add), IMCR (+8.9% shares, wt↑0.20ppt). - Reduced: MIRM (wt↓1.71ppt), PTCT (wt↓1.09ppt); no explicit "Reduce" actions per data. 3. Portfolio structure: Active, concentrated (45 positions), heavily biased toward Health Care (biopharma/therapeutics), with moderate risk appetite (high-conviction bets, no ETFs). 4. Per-holding one-liner: - AUPH: Autoimmune drug developer (Aurinia). - CORT: Corticosteroid therapies (Corcept). - KNSA: Inflammatory/immune disease drugs (Kiniksa). - SYRE: Dermatology-focused biotech (Spyre). - TARS: Anti-infectives developer (Tarsus). - LKFT: Cell therapy biotech (Lakefront). - CELC: Cancer drug platform (Celcuity). - MIRM: Liver disease treatments (Mirum). - PTCT: Rare disease drugs (PTC Therapeutics). - IMCR: T-cell therapies (Immunocore). 5. Style summary: Biotech-focused active manager tactically reallocating capital to high-growth therapeutic candidates while trimming laggards.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 10:11

Sector Allocation

Health Care 89.7%
Other 8.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 13.04M $211.25M 9.72%
9.72%
Hold
2 1.50M $172.84M 7.95%
7.95%
Hold
3 2.26M $168.61M 7.76%
7.76%
Hold
4 1.89M $168.46M 7.75%
7.75%
Hold
5 1.92M $150.75M 6.93%
6.93%
Add
6 3.99M $118.18M 5.44%
5.44%
Add
7 1.46M $116.46M 5.36%
5.36%
Add
8 1.24M $105.66M 4.86%
4.86%
Hold
9 1.50M $97.17M 4.47%
4.47%
Hold
10 2.88M $87.36M 4.02%
4.02%
Add
11 1.47M $74.10M 3.41%
3.41%
Add
12 95.00K $72.45M 3.33%
3.33%
Reduce
13 5.20M $64.69M 2.98%
2.98%
Add
14 6.42M $54.93M 2.53%
2.53%
Hold
15 707.50K $51.40M 2.37%
2.37%
Hold
16 470.00K $46.20M 2.12%
2.12%
Hold
17 1.79M $36.91M 1.70%
1.70%
Hold
18 1.58M $33.33M 1.53%
1.53%
Add
19 20.93M $32.86M 1.51%
1.51%
Add
20 9.05M $30.94M 1.42%
1.42%
New
21 7.08M $26.20M 1.21%
1.21%
Add
22 4.81M $25.08M 1.15%
1.15%
Hold
23 264.69K $23.31M 1.07%
1.07%
Hold
24 17.99M $18.71M 0.86%
0.86%
Hold
25 3.30M $18.48M 0.85%
0.85%
Hold
26 450.00K $17.29M 0.80%
0.80%
Hold
27 1.16M $16.92M 0.78%
0.78%
Hold
28 500.00K $16.30M 0.75%
0.75%
Hold
29 500.00K $16.14M 0.74%
0.74%
New
30 700.00K $13.92M 0.64%
0.64%
New
31 7.29M $12.17M 0.56%
0.56%
Add
32 100.00K $11.41M 0.53%
0.53%
Hold
33 17.84M $11.16M 0.51%
0.51%
Hold
34 1.61M $11.01M 0.51%
0.51%
Hold
35 50.00K $9.63M 0.44%
0.44%
Hold
36 300.00K $7.80M 0.36%
0.36%
Hold
37 2.84M $7.13M 0.33%
Form 4 · 13 →
0.33%
Add
38 6.14M $6.63M 0.30%
0.30%
Hold
39 8.97M $2.81M 0.13%
0.13%
Add
40 600.00K $2.22M 0.10%
0.10%
Hold
41 666.02K $1.90M 0.09%
0.09%
Hold
42 451.11K $1.73M 0.08%
0.08%
Hold
43 125.00K $657.50K 0.03%
0.03%
New
44 200.00K $322.00K 0.01%
0.01%
New
45 100.00K $263.00K 0.01%
0.01%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 80% R 80% F1 80% (modelled on 2026-Q2; 8/10 hit)

Low-confidence forecast This fund replaces about 26% of its Top-10 each quarter and backtests at F1 73% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (11 quarters)

Avg precision 73% · recall 73% · F1 73% · avg rank error 2.5 · Top-10 turnover 26%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 70% 70% 70% MRTX · IMGN · LIANY · TARS · KALV · ANAB · MIRM · EOLS · ALT · IMCR TARS · EOLS · KALV · ANAB · MIRM · ALT · IMCR · INBX · LLY · PCVX
2024-Q2 60% 60% 60% TARS · EOLS · KALV · MIRM · ANAB · ALT · IMCR · INBX · LLY · PCVX TARS · EOLS · KALV · ANAB · ANIP · DVAX · LLY · ACAD · PCVX · PTCT
2024-Q3 50% 50% 50% TARS · EOLS · KALV · ANIP · ANAB · DVAX · ACAD · LLY · PCVX · ITCI EOLS · TARS · AUPH · VRDN · MIRM · KALV · ANAB · IMCR · PCVX · BNTX
2024-Q4 70% 70% 70% EOLS · TARS · AUPH · VRDN · MIRM · KALV · ANAB · IMCR · PCVX · BNTX TARS · AUPH · LKFT · EOLS · MIRM · VRDN · IMCR · KALV · RLAY · REPL
2025-Q1 70% 70% 70% TARS · AUPH · LKFT · EOLS · IMCR · VRDN · MIRM · KALV · RLAY · REPL TARS · LKFT · AUPH · DVAX · EOLS · KALV · IMCR · MIRM · PTCT · KNSA
2025-Q2 90% 90% 90% TARS · LKFT · DVAX · AUPH · IMCR · EOLS · KALV · MIRM · KNSA · PTCT LKFT · TARS · AUPH · IMCR · KNSA · MIRM · KALV · PTCT · SYRE · EOLS
2025-Q3 80% 80% 80% LKFT · TARS · AUPH · KNSA · IMCR · MIRM · PTCT · KALV · SYRE · EOLS TARS · LKFT · AUPH · PTCT · MIRM · KNSA · IMCR · KALV · VRDN · CMPX
2025-Q4 80% 80% 80% TARS · LKFT · AUPH · PTCT · KNSA · MIRM · IMCR · MRUS · CMPX · VRDN AUPH · LKFT · PTCT · CELC · MIRM · TARS · KNSA · IMCR · CMPX · KALV
2026-Q1 70% 70% 70% AUPH · LKFT · PTCT · CELC · MIRM · IMCR · KNSA · CMPX · TARS · KALV AUPH · CELC · MIRM · LKFT · SPY · KNSA · CAPR · PTCT · SYRE · KALV
2026-Q2 80% 80% 80% AUPH · SPY · CELC · CAPR · MIRM · LKFT · KNSA · PTCT · KALV · SYRE AUPH · SYRE · MIRM · KNSA · CELC · CORT · PTCT · LKFT · CAPR · TARS
2026-Q3 ★ 80% 80% 80% AUPH · SYRE · CORT · KNSA · MIRM · CELC · PTCT · LKFT · CAPR · SPY AUPH · CORT · KNSA · SYRE · TARS · LKFT · CELC · MIRM · PTCT · IMCR

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-16. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-16 Trading days33 Holdings5 Model coverage100.0%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-16, and will update as prices arrive.

Portfolio return-25.82%Buy & hold
QQQ synthetic benchmark-17.01%Liquidity weighted
Excess return-8.81%vs benchmark
Barra annualised vol63.1%Model estimate
Realised vol49.2%Annualised in window
Weighted beta1.41Raw exposure
Factor / specific risk35% / 65%Share of variance
Top-10 concentration100.0%Of reported value
Portfolio value (start = 100)71.880.388.997.4105.910-0110-2311-16TANG CAPITAL MANAGEMENT LLCQQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-25.82%Disclosed long book
QQQ synthetic benchmark-17.01%Liquidity-weighted constituents
Model universe, equal weight-1.70%Opportunity-cost reference
Excess return-8.81%Portfolio − benchmark
Arithmetic return sum-28.13%Difference vs compounded is the cross term
Weighted raw beta1.41Weighted holding betas
Realised volatility (annualised)49.20%Daily returns in window
Barra model volatility (annualised)63.07%Factor + specific
Factor share of variance34.8%Barra factors
Specific share of variance65.2%Stock residuals
Reported value$280.3M13F long US equity

2. Return attribution

The -28.13% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 +2.15% 7.6%
Momentum & Growth 3 +2.69% 9.6%
Volatility & Tail Risk 7 +8.96% 31.9%
Industry 12 +7.45% 26.5%
Specific 1 -49.37% -175.5%
Return attribution (style + industry, %)-19.7-9.8+0.0+9.8+19.7Amihud Illiquidity-1.20Turnover+2.23Leverage (Downside Vol)+2.24Other+2.27Max Drawdown+2.33Beta+2.51Non-linear Size+2.85Mid Cap-2.91Growth+3.83Residual Volatility+4.25Health Care+5.18Skewness-8.26Historical Volatility-12.34Kurtosis+18.22
Factor Type Exposure Factor return Contribution Share of |return|
Kurtosis Style +2.43 +7.51% +18.22% 64.8%
Health Care Industry +0.74 +6.98% +5.18% 18.4%
Residual Volatility Style +1.29 +3.29% +4.25% 15.1%
Growth Style +2.20 +1.75% +3.83% 13.6%
Non-linear Size Style +2.83 +1.01% +2.85% 10.1%
Beta Style +0.56 +4.44% +2.51% 8.9%
Max Drawdown Style -1.32 -1.76% +2.33% 8.3%
Other Industry +0.26 +8.78% +2.27% 8.1%
Leverage (Downside Vol) Style -1.31 -1.71% +2.24% 8.0%
Turnover Style -0.46 -4.80% +2.23% 7.9%
Size Style -0.38 -1.95% +0.74% 2.6%
Liquidity Style +1.25 +0.36% +0.44% 1.6%
Short-term Reversal Style -0.31 +0.87% -0.27% -1.0%
Momentum Style +0.22 -4.00% -0.87% -3.1%
Amihud Illiquidity Style +2.69 -0.45% -1.20% -4.3%
Mid Cap Style +1.50 -1.94% -2.91% -10.4%
Skewness Style +1.88 -4.39% -8.26% -29.4%
Historical Volatility Style +0.88 -14.00% -12.34% -43.9%
Specific Specific — — -49.37% -175.5%

3. Risk attribution

Annualised volatility is 63.07%; factor risk explains 34.8% of variance and specific risk 65.2%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-70.4-35.2+0.0+35.2+70.4Leverage (Downside Vol)+0.88Non-linear Size+0.95Historical Volatility+1.43Amihud Illiquidity+1.53Kurtosis+1.56Mid Cap+2.13Max Drawdown+2.13Liquidity+2.24Beta+2.70Residual Volatility+2.79Other+3.82Health Care+4.30Growth+8.20Specific+65.18
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 65.2% +41.11% 41.1%
Growth Style +2.20 8.2% +5.17% 5.2%
Health Care Industry +0.74 4.3% +2.71% 2.7%
Other Industry +0.26 3.8% +2.41% 2.4%
Residual Volatility Style +1.29 2.8% +1.76% 1.8%
Beta Style +0.56 2.7% +1.70% 1.7%
Liquidity Style +1.25 2.2% +1.41% 1.4%
Mid Cap Style +1.50 2.1% +1.35% 1.4%
Max Drawdown Style -1.32 2.1% +1.34% 1.3%
Kurtosis Style +2.43 1.6% +0.98% 1.0%
Amihud Illiquidity Style +2.69 1.5% +0.97% 1.0%
Historical Volatility Style +0.88 1.4% +0.90% 0.9%
Non-linear Size Style +2.83 0.9% +0.60% 0.6%
Leverage (Downside Vol) Style -1.31 0.9% +0.55% 0.6%
Momentum Style +0.22 0.4% +0.26% 0.3%
Short-term Reversal Style -0.31 -0.5% -0.32% -0.3%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.7-0.50.82.03.2Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -0.38 +2.10 -2.48
Non-linear Size +2.83 +1.68 +1.15
Mid Cap +1.50 +0.13 +1.38
Beta +0.56 +1.29 -0.73
Momentum +0.22 +0.72 -0.50
Short-term Reversal -0.31 -0.64 +0.33
Residual Volatility +1.29 -0.40 +1.69
Historical Volatility +0.88 +0.86 +0.02
Liquidity +1.25 +0.11 +1.13
Amihud Illiquidity +2.69 +1.16 +1.53
Turnover -0.46 +0.21 -0.67
Growth +2.19 +0.58 +1.61
Leverage (Downside Vol) -1.31 +0.14 -1.45
Skewness +1.88 +0.24 +1.64
Kurtosis +2.43 +0.21 +2.21
Max Drawdown -1.32 -0.08 -1.24

5. Industry allocation & Brinson

Industry allocation (weight, %)-7.414.837.159.381.6Information TechnologyCommunication ServicesUtilitiesConsumer StaplesConsumer DiscretionaryIndustrialsOtherHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 0.0% 73.6% +0.00% -22.33% +3.83% +16.44% -16.44% +16.44%
Other 25.9% 0.0% +2.16% +0.00% +4.43% +0.00% +0.56% +0.56%
Communication Services 0.0% 2.6% +0.00% -17.64% +0.01% +0.46% -0.46% +0.46%
Utilities 0.0% 0.8% +0.00% +11.13% -0.22% -0.09% +0.09% -0.09%
Consumer Staples 0.0% 0.8% +0.00% +15.26% -0.27% -0.13% +0.13% -0.13%
Consumer Discretionary 0.0% 8.8% +0.00% +3.76% -1.84% -0.33% +0.33% -0.33%
Industrials 0.0% 11.1% +0.00% +4.36% -2.39% -0.48% +0.48% -0.48%
Health Care 74.1% 1.7% -33.56% +8.29% +18.41% -0.72% -30.30% -25.03%
Total +21.84% +15.12% -45.59% -8.63%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
CORT CORCEPT THERAPEUTICS INC Health Care 61.67% -39.93% -24.62% Hold
SPY STATE STR SPDR S&P 500 ETF T Other 25.85% +2.16% +0.56% Reduce
LEGN LEGEND BIOTECH CORP Health Care 4.97% -19.61% -0.97% New
INSM INSMED INC Health Care 4.07% +7.66% +0.31% Hold
MRNA MODERNA INC Health Care 3.44% +11.79% +0.40% Hold
Contribution rank Symbol Sector Weight Return Contribution
1 SPY Other 25.85% +2.16% +0.56%
2 MRNA Health Care 3.44% +11.79% +0.40%
3 INSM Health Care 4.07% +7.66% +0.31%
4 LEGN Health Care 4.97% -19.61% -0.97%
5 CORT Health Care 61.67% -39.93% -24.62%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-16 (33 trading days), the reported portfolio returned -25.82%, versus -17.01% for the QQQ synthetic benchmark — an excess of -8.81%.
  2. Return attribution: the largest positive style/industry contributions came from Kurtosis +18.22%, Health Care +5.18%, Residual Volatility +4.25%; the largest drags came from Historical Volatility -12.34%, Skewness -8.26%, Mid Cap -2.91%. Specific (stock-level) return contributed -49.37%.
  3. Risk attribution: Barra model volatility is 63.07% annualised; factor risk explains 35% of variance and specific risk 65%. The largest factor risk sources are Growth 8.2%, Health Care 4.3%, Other 3.8%.
  4. Style tilt: size -0.38, momentum +0.22, volatility +0.88, liquidity +1.25; the weighted raw beta is 1.41. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+72.4 pp), the largest underweight is Information Technology (-73.6 pp). Allocation contributed +21.84%, selection +15.12% and interaction -45.59%.
  6. Concentration: the top-10 positions are 100.0% of the attributed portfolio and the model covers 100.0% of its value with full style exposures. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did TANG CAPITAL MANAGEMENT LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, TANG CAPITAL MANAGEMENT LLC reported 45 equity positions worth $2.17B in aggregate; its largest disclosed positions were AUPH ($211.25M), CORT ($172.84M), KNSA ($168.61M).

How large is TANG CAPITAL MANAGEMENT LLC's portfolio?

TANG CAPITAL MANAGEMENT LLC reported $2.17B of long equity holdings across 45 positions as of 2026-Q3. Top-10 holdings account for 64.3% of reported value.

What is TANG CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tang-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →